Q32 Bio Inc.

NasdaqGM:QTTB Stock Report

Market Cap: US$40.9m

Q32 Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of QTTB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders75,6920.621%
Public Companies759,1456.23%
General Public1,382,34811.3%
Institutions3,712,25730.5%
VC/PE Firms6,251,25951.3%

Dilution of Shares: QTTB only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 86.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.5%
OrbiMed Advisors LLC
2,252,987US$7.6m0%0.11%
17.2%
Atlas Venture L.P.
2,092,106US$7.0m0%0.88%
9.05%
Abingworth LLP
1,102,741US$3.7m0%3.73%
6.6%
Acorn Bioventures
803,425US$2.7m0%4.36%
6.23%
Bristol-Myers Squibb Company
759,145US$2.6m0%no data
3.5%
FMR LLC
426,169US$1.4m137%no data
3.35%
BlackRock, Inc.
408,659US$1.4m19.4%no data
3.32%
Adage Capital Management, L.P.
404,411US$1.4m0%no data
2.63%
Arch Venture Partners, L.P.
320,482US$1.1m0%0.11%
2.58%
Temasek Holdings (Private) Limited
313,943US$1.1m0%no data
2.34%
The Vanguard Group, Inc.
285,416US$959.0k106%no data
1.56%
Eventide Asset Management, LLC
190,000US$638.4k0%0.01%
1.34%
Harvard Management Company, Inc.
162,965US$547.6k0%0.03%
1.08%
Geode Capital Management, LLC
131,768US$442.7k22.4%no data
0.9%
State Street Global Advisors, Inc.
110,164US$370.1k35.5%no data
0.88%
Woodline Partners LP
106,901US$359.2k0%no data
0.82%
Millennium Management LLC
100,343US$337.2k0%no data
0.63%
Point72 Asset Management, L.P.
76,685US$257.7k0%no data
0.55%
Platinum Investment Management Limited
66,801US$224.5k-25.3%0.01%
0.53%
Ensign Peak Advisors, Inc.
64,481US$216.7k0%no data
0.53%
ADAR1 Capital Management, LLC
64,245US$215.9k-59%0.04%
0.5%
Northern Trust Global Investments
61,255US$205.8k0%no data
0.49%
Shelia Violette
60,151US$202.1k65.8%no data
0.49%
Erste Asset Management GmbH
60,000US$201.6k100%no data
0.46%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
55,886US$187.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 09:50
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Q32 Bio Inc. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBMO Capital Markets Equity Research
Thomas SmithLeerink Partners LLC
Jay OlsonOppenheimer & Co. Inc.